Edition:
United States

Novozymes A/S (NVZMY.PK)

NVZMY.PK on OTC Markets Group

54.51USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$54.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,357
52-wk High
$56.06
52-wk Low
$32.90

Chart for

About

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 26.06 16.04
EPS (TTM): -- -- --
ROI: -- 16.98 34.69
ROE: -- 21.96 15.46

MOVES-Pandora poaches communications director from Novozymes

COPENHAGEN, Dec 6 Danish jewellery maker Pandora said in a statement on Wednesday:

Dec 06 2017

BRIEF-Novozymes CEO Sells 50,000 Of Own Shares

* CEO SELLS 50.000 OF OWN SHARES IN COMPANY FOR A TOTAL VALUE OF DKK 17.2 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Nov 29 2017

BRIEF-Novozymes completes share buyback program

* ‍NOVOZYMES HAS NOW COMPLETED ANNOUNCED SHARE BUYBACK PROGRAM OF B SHARES WORTH UP TO DKK 2 BILLION IN TOTAL DURING 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Nov 10 2017

Novozymes shares surge as bioenergy tops expectations

COPENHAGEN, Oct 25 Denmark's Novozymes reported third-quarter sales and earnings ahead of forecasts on Wednesday and raised its outlook as more powerful enzymes products drove demand from ethanol makers, sending its shares up six percent to a two-year high.

Oct 25 2017

BRIEF-Novozymes Q3 EBIT above expectations at DKK 1.06 bln

* NOVOZYMES - STILL SOME UNCERTAINTY REGARDING AGRICULTURE-RELATED MARKETS IN Q4‍​

Oct 25 2017

BRIEF-Novozymes launches two ethanol enzyme products in Europe

Aug 17 DANISH ENZYMES PRODUCER NOVOZYMES ANNOUNCES

Aug 17 2017

Novozymes shares fall as Q2 pressured by detergent makers, Monsanto alliance

COPENHAGEN, Aug 11 Danish enzymes maker Novozymes undershot market expectations in the second quarter pressured by cost cuts at detergent makers and a changed sales pattern in its cooperation with Monsanto.

Aug 11 2017

BRIEF-Novozymes ‍Q2 EBIT at DKK ‍​963 mln, below expectations

* ‍Q2 EBIT MARGIN AT 28.2%, EXCLUDING REORGANIZATION COSTS (Q2 2016: 28.0%)​

Aug 11 2017

Earnings vs. Estimates